TransEnterix Announces US 510(k) FDA Clearance for Senhance Surgical Robotic System
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/2/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
- Analysis-Excommunications show a Pope Leo unafraid of making firm decisions
- Whirlpool to close Mexico plant, expects $165M restructuring cost
- Meta Platforms stock surges 8% on cloud business plans
- Canaccord Starts Infleqtion, Inc (INFQ) at Buy
- Wall Street ends choppy session lower as tech shares drop
TransEnterix (TRXC) PT Raised to $4.50 at Ladenburg Thalmann
October 17, 2017 11:10 AM EDTLadenburg Thalmann raised its price target on TransEnterix (NYSE: TRXC) to $4.50 (from $3.00) while maintaining a Buy rating.
Analyst Jeffrey Cohen made the change following FDA clearance,
... MoreTransEnterix (TRXC) Adds to Monday's Big Gains
October 17, 2017 9:54 AM EDTTransEnterix (NYSE: TRXC) adds to Monday gains following FDA 510(k) clearance for the Senhance Surgical Robotic System.
Shares are up 25.6% in early trading after gaining 93% Monday.
... More